UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 143

Sortiert nach

Advantages and Disadvantages of Inclisiran: A Small Interfering Ribonucleic Acid Molecule Targeting PCSK9—A Narrative Review

Cardiovascular therapeutics, 2022-02, Vol.2022, p.8129513-6

2022

Link zum Volltext

Verfügbarkeit prüfen

Effect of Hydroxychloroquine and Azithromycin on QT Interval Prolongation and Other Cardiac Arrhythmias in COVID-19 Confirmed Patients

Cardiovascular therapeutics, 2021, Vol.2021, p.6683098-7

2021

Link zum Volltext

Verfügbarkeit prüfen

Effect of Adiponectin Variant on Lipid Profile and Plasma Adiponectin Levels: A Multicenter Systematic Review and Meta-Analysis

Cardiovascular therapeutics, 2022-07, Vol.2022, p.1-18

2022

Link zum Volltext

Verfügbarkeit prüfen

LCZ696 Therapy Reduces Ventricular Tachyarrhythmia Inducibility in a Myocardial Infarction-Induced Heart Failure Rat Model

Cardiovascular therapeutics, 2019-01, Vol.2019, p.6032631-9

2019

Link zum Volltext

Verfügbarkeit prüfen

Musculoskeletal Adverse Events Associated with PCSK9 Inhibitors: Disproportionality Analysis of the FDA Adverse Event Reporting System

Cardiovascular therapeutics, 2022-01, Vol.2022, p.9866486-9

2022

Link zum Volltext

Verfügbarkeit prüfen

Vericiguat: A New Hope for Heart Failure Patients

Cardiovascular therapeutics, 2022, Vol.2022, p.1554875

2022

Link zum Volltext

Verfügbarkeit prüfen

Noncoding RNA in the Regulation of Acute Aortic Dissection: From Profile to Mechanism

Cardiovascular therapeutics, 2022-11, Vol.2022, p.2371401-6

2022

Link zum Volltext

Verfügbarkeit prüfen

Role of Traditional Cardiovascular Risk Factors after Initiation of Statin Therapy: A PharmLines Inception Cohort Study

Cardiovascular therapeutics, 2022-05, Vol.2022, p.6587165-9

2022

Link zum Volltext

Verfügbarkeit prüfen

L-Carnitine Alleviates the Myocardial Infarction and Left Ventricular Remodeling through Bax/Bcl-2 Signal Pathway

Cardiovascular therapeutics, 2022-05, Vol.2022, p.9615674-10

2022

Link zum Volltext

Verfügbarkeit prüfen

Oridonin Relieves Angiotensin II-Induced Cardiac Remodeling via Inhibiting GSDMD-Mediated Inflammation

Cardiovascular therapeutics, 2022-03, Vol.2022, p.3167959-17

2022

Link zum Volltext

Verfügbarkeit prüfen

Aberrant Mitochondrial Dynamics: An Emerging Pathogenic Driver of Abdominal Aortic Aneurysm

Cardiovascular therapeutics, 2021-06, Vol.2021, p.1-9

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinical Nomogram to Predict Major Adverse Cardiac Events in Acute Myocardial Infarction Patients within 1 Year of Percutaneous Coronary Intervention

Cardiovascular therapeutics, 2021-12, Vol.2021, p.3758320-9

2021

Link zum Volltext

Verfügbarkeit prüfen

Abdominal Obesity Is Associated with an Increased Risk of All-Cause Mortality in Males but Not in Females with HFpEF

Cardiovascular therapeutics, 2022, Vol.2022, p.2950055-11

2022

Link zum Volltext

Verfügbarkeit prüfen

Association between Platelet to Neutrophil Ratio (PNR) and Clinical Outcomes in STEMI Patients after Successful pPCI: A Secondary Analysis Based on a Cohort Study

Cardiovascular therapeutics, 2022-02, Vol.2022, p.2022657-8

2022

Link zum Volltext

Verfügbarkeit prüfen

The Effect of 3-Month Growth Hormone Administration and 12-Month Follow-Up Duration among Heart Failure Patients Four Weeks after Myocardial Infarction: A Randomized Double-Blinded Clinical Trial

Cardiovascular therapeutics, 2021, Vol.2021, p.2680107-9

2021

Link zum Volltext

Verfügbarkeit prüfen

A Nomogram Based on Apelin-12 for the Prediction of Major Adverse Cardiovascular Events after Percutaneous Coronary Intervention among Patients with ST-Segment Elevation Myocardial Infarction

Cardiovascular therapeutics, 2020, Vol.2020, p.9416803-10

2020

Link zum Volltext

Verfügbarkeit prüfen

Drug-Coated Balloon for De Novo Coronary Artery Lesions: A Systematic Review and Trial Sequential Meta-analysis of Randomized Controlled Trials

Cardiovascular therapeutics, 2020, Vol.2020, p.4158363-10

2020

Link zum Volltext

Verfügbarkeit prüfen

The Effect of Early Treatment with Intravenous Magnesium Sulfate on the Incidence of Cardiac Comorbidities in Hospitalized Stroke Patients

Cardiovascular therapeutics, 2020-09, Vol.2020, p.1494506-8

2020

Link zum Volltext

Verfügbarkeit prüfen

Predictive Value of Electromechanical Activation Time for In-Hospital Major Cardiac Adverse Events in Heart Failure Patients

Cardiovascular therapeutics, 2020, Vol.2020, p.4532596-6

2020

Link zum Volltext

Verfügbarkeit prüfen

The Functional Severity Assessment of Coronary Stenosis Using Coronary Computed Tomography Angiography-Based Myocardial Mass at Risk and Minimal Lumen Diameter

Cardiovascular therapeutics, 2020, Vol.2020, p.6716130-10

2020

Link zum Volltext

Verfügbarkeit prüfen

Identification of Genetic Biomarkers for Diagnosis of Myocardial Infarction Compared with Angina Patients

Cardiovascular therapeutics, 2020, Vol.2020, p.8535314-12

2020

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Prognosis of Suspected Myocarditis and Cardiomyopathy Associated with Viral Infection of the Myocardial Tissue: A Meta-Analysis of Cohort Studies

Cardiovascular therapeutics, 2019, Vol.2019, p.9342792-10

2019

Link zum Volltext

Verfügbarkeit prüfen

Comparison of the Effect of Fimasartan versus Valsartan on Blood Pressure Variability in Acute Ischemic Stroke: A Double-Blind Randomized Trial

Cardiovascular therapeutics, 2019-01, Vol.2019, p.7836527-8

2019

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the pharmacokinetics and drug interactions of the two recently developed statins, rosuvastatin and pitavastatin

Expert opinion on drug metabolism & toxicology, 2014-01, Vol.10 (1), p.51-65

2014

Link zum Volltext

Verfügbarkeit prüfen

The beneficial effects of Ganoderma lucidum on cardiovascular and metabolic disease risk

Pharmaceutical biology, 2021-01, Vol.59 (1), p.1159-1169

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 143

Suche als RSS-Feed

Aktive Filter

ThemaPharmacology & Pharmacy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(138)
Mit Volltextzugriff
(97)

Publikationsform

Artikel
(143)

Sprache

Englisch
(143)
Japanisch
(22)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Advantages and Disadvantages of Inclisiran: A Small Interfering Ribonucleic Acid Molecule Targeting PCSK9—A Narrative Review

Effect of Hydroxychloroquine and Azithromycin on QT Interval Prolongation and Other Cardiac Arrhythmias in COVID-19 Confirmed Patients

Effect of Adiponectin Variant on Lipid Profile and Plasma Adiponectin Levels: A Multicenter Systematic Review and Meta-Analysis

LCZ696 Therapy Reduces Ventricular Tachyarrhythmia Inducibility in a Myocardial Infarction-Induced Heart Failure Rat Model

Musculoskeletal Adverse Events Associated with PCSK9 Inhibitors: Disproportionality Analysis of the FDA Adverse Event Reporting System

Vericiguat: A New Hope for Heart Failure Patients

Noncoding RNA in the Regulation of Acute Aortic Dissection: From Profile to Mechanism

Role of Traditional Cardiovascular Risk Factors after Initiation of Statin Therapy: A PharmLines Inception Cohort Study

L-Carnitine Alleviates the Myocardial Infarction and Left Ventricular Remodeling through Bax/Bcl-2 Signal Pathway

Oridonin Relieves Angiotensin II-Induced Cardiac Remodeling via Inhibiting GSDMD-Mediated Inflammation

Aberrant Mitochondrial Dynamics: An Emerging Pathogenic Driver of Abdominal Aortic Aneurysm

Clinical Nomogram to Predict Major Adverse Cardiac Events in Acute Myocardial Infarction Patients within 1 Year of Percutaneous Coronary Intervention

Abdominal Obesity Is Associated with an Increased Risk of All-Cause Mortality in Males but Not in Females with HFpEF

Association between Platelet to Neutrophil Ratio (PNR) and Clinical Outcomes in STEMI Patients after Successful pPCI: A Secondary Analysis Based on a Cohort Study

The Effect of 3-Month Growth Hormone Administration and 12-Month Follow-Up Duration among Heart Failure Patients Four Weeks after Myocardial Infarction: A Randomized Double-Blinded Clinical Trial

A Nomogram Based on Apelin-12 for the Prediction of Major Adverse Cardiovascular Events after Percutaneous Coronary Intervention among Patients with ST-Segment Elevation Myocardial Infarction

Drug-Coated Balloon for De Novo Coronary Artery Lesions: A Systematic Review and Trial Sequential Meta-analysis of Randomized Controlled Trials

The Effect of Early Treatment with Intravenous Magnesium Sulfate on the Incidence of Cardiac Comorbidities in Hospitalized Stroke Patients

Predictive Value of Electromechanical Activation Time for In-Hospital Major Cardiac Adverse Events in Heart Failure Patients

The Functional Severity Assessment of Coronary Stenosis Using Coronary Computed Tomography Angiography-Based Myocardial Mass at Risk and Minimal Lumen Diameter

Identification of Genetic Biomarkers for Diagnosis of Myocardial Infarction Compared with Angina Patients

Long-Term Prognosis of Suspected Myocarditis and Cardiomyopathy Associated with Viral Infection of the Myocardial Tissue: A Meta-Analysis of Cohort Studies

Comparison of the Effect of Fimasartan versus Valsartan on Blood Pressure Variability in Acute Ischemic Stroke: A Double-Blind Randomized Trial

Evaluation of the pharmacokinetics and drug interactions of the two recently developed statins, rosuvastatin and pitavastatin

The beneficial effects of Ganoderma lucidum on cardiovascular and metabolic disease risk

Aktive Filter

Suchergebnisse filtern